Ovarian Cancer Early Detection Tool – New Breakthrough
- A new risk assessment tool, developed by researchers at Queen Mary University of London, coudl substantially improve early detection of ovarian cancer and, consequently, patient survival rates.
- OvaTools doesn't replace existing diagnostic procedures but aims to refine the process of identifying patients who require further examination.
- A recent study, based on data from over 800 women, showed that the tool could identify a notable proportion of women with ovarian cancer who might otherwise have...
“`html
New Risk Assessment Tool Shows Promise for Earlier Ovarian Cancer Detection
Table of Contents
A new risk assessment tool, developed by researchers at Queen Mary University of London, coudl substantially improve early detection of ovarian cancer and, consequently, patient survival rates. The tool, called OvaTools, combines standard blood test results measuring CA125 levels (a tumor marker) with patient age to generate a personalized ovarian cancer risk score.
How OvaTools Works
OvaTools doesn’t replace existing diagnostic procedures but aims to refine the process of identifying patients who require further examination. Currently, CA125 blood tests are used, but their accuracy is limited as elevated levels can also indicate benign conditions. by integrating CA125 levels with age, OvaTools provides a more nuanced risk assessment.
A recent study, based on data from over 800 women, showed that the tool could identify a notable proportion of women with ovarian cancer who might otherwise have been missed. The study’s findings were published in the BJOG: An International Journal of Obstetrics & Gynaecology on September 12, 2024. BJOG is a leading peer-reviewed journal in the field.
The Importance of Early Diagnosis
Ovarian cancer is often called the “silent killer” because symptoms can be vague and easily attributed to other, less serious conditions. Possible symptoms include abdominal pain, bloating, loss of appetite, and changes in bowel or urinary habits.
However, early diagnosis is crucial. According to Cancer Research UK, five-year survival rates exceed 90% when ovarian cancer is detected at stage I, but this drops dramatically to around 16% at stage IV.Cancer Research UK provides detailed statistics on ovarian cancer survival rates.
| Stage | 5-Year Survival Rate (UK) |
|---|---|
| Stage I | >90% |
| Stage II | 70-85% |
| Stage III | 30-50% |
| Stage IV | <16% |
Impact on Primary Care
The researchers emphasize that OvaTools is intended to assist family doctors in identifying higher-risk patients who should be referred for specialized care. It is not a standalone diagnostic tool. The tool aims to improve the efficiency of the diagnostic pathway, reducing delays in referral and potentially leading to earlier treatment.
While the current evidence is promising, specialists agree that further studies are needed to evaluate the tool’s impact in real-world clinical practice. These studies will focus on assessing the tool